GlaxoSmithKline said it appointed Hal Barron as its next chief scientific officer, snagging one of the pharmaceutical industry’s leading research luminaries to bolster its flagging drug pipeline.
from WSJ.com: US Business http://ift.tt/2zsMjRE
via IFTTT
No comments:
Post a Comment